Seftos TZ 250mg/31.25mg Injection
Marketer
Smile Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Seftos TZ 250mg/31.25mg Injection
Tazicef 250mg/31.25mg injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under a physician's direction; adhere strictly to the prescribed schedule. Complete the full course of treatment, even with symptom improvement; premature cessation may compromise efficacy. Common adverse reactions include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek urgent medical attention for allergic responses (rash, pruritus, edema, dyspnea). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor therapeutic response.
Uses of Seftos TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Seftos TZ 250mg/31.25mg Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Seftos TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Seftos TZ 250mg/31.25mg Injection:
Administering this medication will be done by your physician or their qualified assistant; please do not self-medicate.
How Seftos TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Seftos TZ 250mg/31.25mg Injection, offer a dual-action antibiotic approach. Ceftriaxone's mechanism disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Seftos TZ 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Seftos TZ (250mg/31.25mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal to no negative impacts on fetal development; nonetheless, research involving human subjects is scarce.
Breast feedingCAUTION
Administering Seftos TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Seftos TZ 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Operation of vehicles is contraindicated while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Seftos TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Seftos TZ 250mg/31.25mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Seftos TZ 250mg/31.25mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Seftos TZ 250mg/31.25mg Injection :
Omitting a scheduled dose of Seftos TZ 250mg/31.25mg Injection necessitates contacting your physician.
Facts to Know About Seftos TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently